InflaRx (IFRX) Invested Capital (2022 - 2025)

InflaRx's Invested Capital history spans 3 years, with the latest figure at $65.6 million for Q4 2024.

  • For Q4 2024, Invested Capital rose 726.27% year-over-year to $65.6 million; the TTM value through Dec 2024 reached $65.6 million, up 726.27%, while the annual FY2024 figure was $66.5 million, 732.43% up from the prior year.
  • Invested Capital for Q4 2024 was $65.6 million at InflaRx, up from $7.9 million in the prior quarter.
  • Across five years, Invested Capital topped out at $90.1 million in Q4 2022 and bottomed at $7.9 million in Q4 2023.
  • The 3-year median for Invested Capital is $65.6 million (2024), against an average of $54.6 million.
  • The largest annual shift saw Invested Capital tumbled 91.19% in 2023 before it soared 726.27% in 2024.
  • A 3-year view of Invested Capital shows it stood at $90.1 million in 2022, then crashed by 91.19% to $7.9 million in 2023, then skyrocketed by 726.27% to $65.6 million in 2024.
  • Per Business Quant, the three most recent readings for IFRX's Invested Capital are $65.6 million (Q4 2024), $7.9 million (Q4 2023), and $90.1 million (Q4 2022).